Dogs immunized with LBSap vaccine displayed high levels of IL-12 and IL-10 cytokines and CCL4, CCL5 and CXCL8 chemokines in the dermis

Molecular Immunology

Volumn 56, Issue 4, 2013, Pages 540-548

  Vitoriano Souza, Juliana ^a   Moreira, Nádia das Dores ^a   Menezes Souza, Daniel ^b   Roatt, Bruno Mendes ^a   De Oliveira Aguiar Soares, Rodrigo Dian ^a   Siqueira Mathias, Fernando Augusto ^a   De Oliveira Cardoso, Jamille Mirelle ^a   Giunchetti, Rodolfo Cordeiro ^a,b   De Sá, Renata Guerra ^a   Corrêa Oliveira, Rodrigo ^b   Carneiro, Cláudia Martins ^a   Reis, Alexandre Barbosa ^a,c  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Instituto Nacional de Ciencia e Tecnologia em Doencas Tropicais INCT DT   (Brazil)

Author keywords

Adjuvants; Canine visceral leishmaniasis; Chemokines; Cytokines; Real time PCR; Saponin; Vaccine

Indexed keywords

ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8; LEISHMANIA BRAZILIENSIS ANTIGEN PLUS SAPONIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SAPONIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINE; CHEMOKINE; CYTOKINE; LEISHMANIA VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DERMIS; GENE EXPRESSION; IMMUNIZATION; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; MALE; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VISCERAL LEISHMANIASIS; ANIMAL; DOG; DOG DISEASES; FEMALE; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; VETERINARY;

ANIMALS; CHEMOKINE CCL4; CHEMOKINE CCL5; CHEMOKINES; CYTOKINES; DERMIS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; IMMUNIZATION; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-8; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS VACCINES; LEISHMANIASIS, VISCERAL; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAPONINS; TIME FACTORS;

EID: 84881092502     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.05.231     Document Type: Article

References (47)

1. Badolato R., Sacks D.L., Savoia D., Musso T. Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. Experimental Parasitology 1996, 82:21-26.
2. Borja-Cabrera G.P., Cruz Mendes A., Paraguai de Souza E., Hashimoto Okada L.Y., de A.T.F.A., Kawasaki J.K., et al. Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine. Vaccine 2004, 22:2234-2243.
3. Brachelente C., Muller N., Doherr M.G., Sattler U., Welle M. Cutaneous leishmaniasis in naturally infected dogs is associated with a T helper-2-biased immune response. Veterinary Pathology 2005, 42:166-175.
4. Carrillo E., Moreno J. Cytokine profiles in canine visceral leishmaniasis. Veterinary Immunology and Immunopathology 2009, 128:67-70.
5. Chamizo C., Moreno J., Alvar J. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Veterinary Immunology and Immunopathology 2005, 103:67-75.
6. da Silva V.O., Borja-Cabrera G.P., Correia Pontes N.N., de Souza E.P., Luz K.G., Palatnik M., et al. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine 2000, 19:1082-1092.
7. De Waal Malefyt R., Figdor C.G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., de Vries J.E. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-g or IL-10. Journal of Immunology 1993, 151:6370.
8. Deane L.M., Deane M.P. Leishmaniose visceral urbana (no cão e no homem) em Sobral, Ceará. Hospital 1995, 75-87.
9. Desjeux P. Leishmaniasis: current situation and new perspectives. Comparative Immunology, Microbiology and Infectious Diseases 2004, 27:305-318.
10. Giunchetti R.C., Correa-Oliveira R., Martins-Filho O.A., Teixeira-Carvalho A., Roatt B.M., De Oliveira Aguiar-Soares R.D., et al. Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs. Vaccine 2007, 25:7674-7686.
11. Giunchetti R.C., Reis A.B., da Silveira-Lemos D., Martins-Filho O.A., Correa-Oliveira R., Bethony J., et al. Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis. Research in Veterinary Science 2008, 85:106-112.
12. Giunchetti R.C., Correa-Oliveira R., Martins-Filho O.A., Teixeira-Carvalho A., Roatt B.M., De Oliveira Aguiar-Soares R.D., et al. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs. Vaccine 2008, 26:623-638.
13. Gradoni L. An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine. Veterinary Parasitology 2001, 100:87-103.
14. Gupta G., Dey R., Bhattacharyya S., Majumdar S. Role of exogenous chemokines as immunotherapeutic tool against visceral leishmaniasis. Science Against Microbial Pathogens: Communicating Current Research and Technological Advances 2011, 605-612.
15. Hommel M., Jaffe C.L., Travi B., Milon G. Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Annals of Tropical Medicine and Parasitology 1995, 89(Suppl. 1):55-73.
16. Kornbluth R.S., Oh P.S., Munis J.R., Cleveland P.H., Richman D.D. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. Journal of Experimental Medicine 1989, 169:1137.
17. Lage R.S., Oliveira G.C., Busek S.U., Guerra L.L., Giunchetti R.C., Correa-Oliveira R., et al. Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi. Veterinary Immunology and Immunopathology 2007, 115:135-145.
18. Lasri S., Sahibi H., Sadak A., Jaffe C.L., Rhalem A. Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes. Veterinary Research 1999, 30:441-449.
19. Lemesre J.L., Holzmuller P., Cavaleyra M., Goncalves R.B., Hottin G., Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 2005, 23:2825-2840.
20. Lemesre J.L., Holzmuller P., Goncalves R.B., Bourdoiseau G., Hugnet C., Cavaleyra M., et al. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Vaccine 2007, 25:4223-4234.
21. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
22. Marshall J.D., Robertson S.E., Trinchieri G., Chehimi J. Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients. Journal of Immunology 1997, 159:5705.
23. Mauel J. Vaccination against Leishmania infections. Current Drug Targets: Immune, Endocrine and Metabolic Disorders 2002, 2:201-226.
24. Mayrink W., Genaro O., Silva J.C., da Costa R.T., Tafuri W.L., Toledo V.P., et al. Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs. Memorias do Instituto Oswaldo Cruz 1996, 91:695-697.
25. Menezes-Souza D., Correa-Oliveira R., Guerra-Sa R., Giunchetti R.C., Teixeira-Carvalho A., Martins-Filho O.A., et al. Cytokine and transcription factor profiles in the skin of dogs naturally infected by Leishmania (Leishmania) chagasi presenting distinct cutaneous parasite density and clinical status. Veterinary Parasitology 2011, 177:39-49.
26. Meylan P.R., Spina C.A., Richman D.D., Kornbluth R.S. In vitro differentiation of monocytoid THP-1 cells affects their permissiveness for HIV strains: a model system for studying the cellular basis of HIV differential tropism. Virology 1993, 193:256-267.
27. Moreira N., Giunchetti R.C., Carneiro C.M., Vitoriano-Souza J., Roatt B.M., Malaquias L.C., et al. Histological study of cell migration in the dermis of hamsters after immunisation with two different vaccines against visceral leishmaniasis. Veterinary Immunology and Immunopathology 2009, 128:418-424.
28. Murray H.W., Tsai C.W., Liu J., Ma X. Visceral Leishmania donovani infection in interleukin-13-/- mice. Infection and Immunity 2006, 74:2487-2490.
29. Panaro M.A., Acquafredda A., Lisi S., Lofrumento D.D., Mitolo V., Sisto M., et al. Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes. Comparative Immunology, Microbiology and Infectious Diseases 2001, 24:187-195.
30. Peruhype-Magalhaes V., Martins-Filho O.A., Prata A., Silva Lde A., Rabello A., Teixeira-Carvalho A., et al. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clinical and Experimental Immunology 2006, 146:124-132.
31. Quinnell R.J., Courtenay O., Shaw M.A., Day M.J., Garcez L.M., Dye C., et al. Tissue cytokine responses in canine visceral leishmaniasis. Journal of Infectious Diseases 2001, 183:1421-1424.
32. Raziuddin S., Abdalla R.E., el-Awad E.H., al-Janadi M. Immunoregulatory and proinflammatory cytokine production in visceral and cutaneous leishmaniasis. Journal of Infectious Diseases 1994, 170:1037-1040.
33. Roatt B.M., Aguiar-Soares R.D., Vitoriano-Souza J., Coura-Vital W., Braga S.L., Correa-Oliveira R., et al. Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation. PLoS ONE 2012, 7:e49780.
34. Robert T., Bailer A.H., Sun Junwei, Joseph B.Margolick, Martin Melissa, Kostman Jay, Montaner Luis J. IL-13 and IFN-g secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression. The Journal of Immunology 1999, 7534-7542.
35. Rot A., von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annual Review of Immunology 2004, 22:891-928.
36. Santiago H.C., Oliveira C.F., Santiago L., Ferraz F.O., de Souza D.G., de-Freitas L.A., et al. Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infection and Immunity 2004, 72:4918-4923.
37. Santos-Gomes G.M., Rosa R., Leandro C., Cortes S., Romao P., Silveira H. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. Veterinary Immunology and Immunopathology 2002, 88:21-30.
38. Stewart R.J., Holloway L.J., Isbister W.H. Peritoneal neutrophilia: a potential indicator of the surgical acute abdomen. Australian and New Zealand Journal of Surgery 1984, 54:565-568.
39. Strauss-Ayali D., Baneth G., Shor S., Okano F., Jaffe C.L. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs. International Journal for Parasitology 2005, 35:63-73.
40. Strauss-Ayali D., Baneth G., Jaffe C.L. Splenic immune responses during canine visceral leishmaniasis. Veterinary Research 2007, 38:547-564.
41. Teixeira C.R., Teixeira M.J., Gomes R.B., Santos C.S., Andrade B.B., Raffaele-Netto I., et al. Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment. Journal of Immunology 2005, 175:8346-8353.
42. Teixeira M.J., Teixeira C.R., Andrade B.B., Barral-Netto M., Barral A. Chemokines in host-parasite interactions in leishmaniasis. Trends in Parasitology 2006, 22:32-40.
43. van Zandbergen G., Hermann N., Laufs H., Solbach W., Laskay T. Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes. Infection and Immunity 2002, 70:4177-4184.
44. van Zandbergen G., Klinger M., Mueller A., Dannenberg S., Gebert A., Solbach W., et al. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. Journal of Immunology 2004, 173:6521-6525.
45. Venuprasad K., Banerjee P.P., Chattopadhyay S., Sharma S., Pal S., Parab P.B., et al. Human neutrophil-expressed CD28 interacts with macrophage B7 to induce phosphatidylinositol 3-kinase-dependent IFN-gamma secretion and restriction of Leishmania growth. Journal of Immunology 2002, 169:920-928.
46. Vitoriano-Souza J., Reis A.B., Moreira N.D., Giunchetti R.C., Correa-Oliveira R., Carneiro C.M. Kinetics of cell migration to the dermis and hypodermis in dogs vaccinated with antigenic compounds of Leishmania braziliensis plus saponin. Vaccine 2008, 26:3922-3931.
47. Vouldoukis I., Drapier J.C., Nussler A.K., Tselentis Y., Da Silva O.A., Gentilini M., et al. Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the l-arginine nitric oxide pathway. Antimicrobial Agents and Chemotherapy 1996, 40:253-256.